Back to results
CompletedPhase 2

N-DOSE: A Dose Optimization Trial of Nicotinamide Riboside in Parkinson's Disease

NCT05589766

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Haukeland University Hospital

Bergen, Vestland, Norway

View on ClinicalTrials.gov
N-DOSE: A Dose Optimization Trial of Nicotinamide Riboside in Parkinson's Disease — TrialFind